A Medical Device Daily

Seegene (Rockville, Maryland) and Shimadzu (Kyoto, Japan) have reported a strategic partnership to combine Seegene's Seeplex multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform.

Shimadzu and Seegene will collaborate on integrating the Seeplex PCR-based tests with Shimadzu's MultiNA high-speed electrophoresis system to provide a highly sensitive, high-throughput, multi-pathogen detection and analysis solution.

"This strategic agreement reinforces our plan to bring solutions, and not only products, to our customers," said Jong-Yoon Chun, Seegene's CEO and founder. "Shimadzu's MultiNA is outstanding in the market for electrophoresis analysis and a perfect match for the Seeplex family of multi-pathogen tests."

Yoshiyuki Togawa, general manager for Shimadzu, said, "Seegene's novel multi-pathogen detection test working with [our] next-generation electrophoresis systems creates an unparalleled screening platform for laboratories around the world. Seeplex tests running on MultiNA is the fast, accurate and efficient way for laboratories to screen for the most rampant and debilitating pathogens infecting people around worldwide."

Shimadzu''s MultiNA is a microchip electrophoresis system that quickly and easily performs DNA and RNA nucleic acid size confirmation and quantification. The system uses microchip technology to conduct fully automated high-speed electrophoresis separation, and fluorescence detection to perform high-sensitivity analysis.

Seeplex tests are based on a multiplexing PCR technology capable of detecting multiple pathogens in a single tube. The company said those tests deliver maximum specificity, reproducibility and sensitivity and can be applied to a broad range of molecular diagnostics, including human, animal, plant and microorganism.

Seegene's Seeplex multi-pathogen detection tests offer labs worldwide simple, cost-effective and comprehensive screening for sexually transmitted diseases, respiratory viruses, human papillomaviruses, sepsis and pneumonia.

In other agreements/contracts news:

Roche Diagnostics (Basel, Switzerland) and Agilent Technologies (Santa Clara, California) have entered into a non-exclusive licensing agreement for use of Roche's melting curve analysis technology. Under the terms of the agreement, Agilent will obtain from Roche a non-exclusive license to use, develop and sell products based on melting curve analysis.

Financial terms of the agreement were not disclosed.

The melting curve analysis is a technique for analysis of PCR products. After PCR, the resulting PCR product is slowly heated. Each double-stranded DNA has its own specific melting temperature, which is defined as the temperature at which 50% of the DNA becomes single stranded. By measurement of the melting temperature, the DNA can be easily identified.

Roche also reported entering into a partnership that will allow it to market the first line of cardiovascular tests for Response Biomedical's (Vancouver, British Columbia) new point-of-care platform.

The platform, the RAMP 200 (Rapid Analyte Measurement Platform), is based on RAMP technology that already is used in laboratories worldwide for West Nile virus, biodefense tests and the recently FDA-cleared RAMP Flu A/B Test.

Kinetic Concepts (KCI; San Antonio) reported that it has entered into an agreement with 3M Health Care (St. Paul, Minnesota) for the supply of 3M Tegaderm brand transparent film dressings for inclusion in KCI kits with KCI's V.A.C. Therapy System in the treatment of complex, hard-to-heal wounds.

The newly-designed 3M Tegaderm dressing, configured exclusively for use with V.A.C. Therapy, will provide a skin-friendly interface that conforms to the body and flexes with skin for greater patient comfort. Additionally, 3M said this dressing will be simpler for healthcare professionals to apply.

Emergency Medical Services (Greenwood, Colorado) said that it has entered into an agreement as a national provider of hospital-based physician services (emergency department, hospitalist and radiology), and ground and fixed-wing air ambulance transportation services to Universal Health Services (UHS; King of Prussia, Pennsylvania) facilities.

UHS is a healthcare management company that through its subsidiaries owns and operates more than 154 acute-care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

In a separate agreement, Emergency Medical Services said that its American Medical Response segment has entered into an agreement with Monterey County, California, to provide 911 emergency and non-emergency ambulance services. The one-year agreement, which commences Sept. 1, is expected to contribute roughly 19,000 transports and $15 million in new revenue.

Del Global Technologies (Franklin Park, Illinois) reported that it has signed an exclusive agreement with New Medical Imaging (NMI; Taiwan) to sell and market NMI's Gemini family of full-field, portable direct radiography (DR) flat panels in the Americas.

"The Gemini products clearly demonstrate what Del is all about. We're offering the latest flat panel technology to our customers in a way that makes sense for them," said Dennis Runyan, VP of sales. "We understand the sizeable investments our customers have already made in our products. With the introduction of the Gemini DR flat panels, we are offering an exclusive, cost-effective upgrade option that allows healthcare providers to take the next step in digital radiography while maintaining their current equipment."

The TriZetto Group (Newport Beach, California) reported a three-year, renewable contract with Syntel (Troy, Michigan) to become a TriZetto multisourcing partner. The Syntel relationship provides greater flexibility and capacity in TriZetto's new product development, professional services delivery and hosted services for its payer customers and strengthens 24/7 operations and services.

TriZetto's multisourcing approach combines on-shore, near-shore and off-shore resources to provide IT services for payers.

Premier Purchasing Partners (Charlotte, North Carolina) said new agreements for chart paper and related products have been awarded to Covidien (Mansfield, Massachusetts) and Print Media (Miami). The 36-month agreements, effective Sept. 1, are available for acute-care and continuum-of-care Premier members.

DiaLog (Wilmington, North Carolina), a wholly owned subsidiary of Inclinix, signed a joint agreement with DeliverMed Holdings, an Illinois-based diabetes specialty home delivery pharmacy. DiaLog's featured product, the DiaLog System, promotes compliance and adherence to blood glucose testing to help diabetic patients and their physicians better manage their disease.

DeliverMed complements the DiaLog System as a major delivery supplier of prescription medications and glucose testing supplies across the U.S.

American Imaging Management (AIM; Chicago), an operating subsidiary of WellPoint, said that it has reached an agreement to provide diagnostic imaging management services for Blue Cross and Blue Shield of Vermont (Montpelier).

"AIM appreciates the opportunity to work with Blue Cross and Blue Shield of Vermont," said Brandon Cady, president of AIM. "We recognize the ... role that BCBSVT has within the Vermont healthcare community and look forward to working with BCBSVT to provide a high level of service and clinical expertise to that community."

AIM provides solutions for managing advanced imaging services.